Harbor Investment Advisory, LLC Affimed N.V. Transaction History

Harbor Investment Advisory, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 26, 2024	SELL	$0.32 - $0.62 $640 - $1,240	-2,000 Reduced 3.29%	58,700 $36,000
Q3 2023 Oct 13, 2023	SELL	$0.46 - $0.65 $690 - $975	-1,500 Reduced 2.41%	60,700 $29,000
Q1 2023 Apr 21, 2023	SELL	$0.66 - $1.29 $8,910 - $17,415	-13,500 Reduced 17.83%	62,200 $46,000
Q4 2022 Jan 24, 2023	SELL	$1.1 - $2.45 $19,800 - $44,100	-18,000 Reduced 19.21%	75,700 $0
Q3 2022 Nov 01, 2022	SELL	$1.96 - $3.32 $6,076 - $10,292	-3,100 Reduced 3.2%	93,700 $193,000
Q2 2022 Jul 18, 2022	SELL	$2.27 - $4.86 $51,983 - $111,294	-22,900 Reduced 19.13%	96,800 $268,000
Q1 2022 Apr 20, 2022	SELL	$3.69 - $5.65 $329,148 - $503,980	-89,200 Reduced 42.7%	119,700 $523,000
Q4 2021 Jan 10, 2022	SELL	$5.37 - $7.07 $20,406 - $26,866	-3,800 Reduced 1.79%	208,900 $1.15 Million
Q3 2021 Oct 12, 2021	BUY	$5.54 - $7.51 $132,960 - $180,240	24,000 Added 12.72%	212,700 $1.31 Million
Q2 2021 Jul 27, 2021	SELL	$7.78 - $11.4 $53,682 - $78,660	-6,900 Reduced 3.53%	188,700 $1.6 Million
Q1 2021 Apr 16, 2021	BUY	$5.12 - $8.48 $299,520 - $496,080	58,500 Added 42.67%	195,600 $1.55 Million
Q4 2020 Feb 04, 2021	BUY	$3.16 - $7.03 $341,596 - $759,943	108,100 Added 372.76%	137,100 $798,000
Q3 2020 Oct 23, 2020	BUY	$3.26 - $4.73 $3,260 - $4,730	1,000 Added 3.57%	29,000 $98,000
Q4 2019 Jan 16, 2020	BUY	$2.25 - $3.07 $63,000 - $85,960	28,000 New	28,000 $77,000

1.09M

Ticker AFMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 149,339,008
Market Cap $185M
Description
Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Its lead product candidate is AFM13, which has completed Phase II clinical study for peripheral T-cell lymphoma; in Phase IIa clinical trial for CD30-positive lymphoma; and in P...

Get notified when there are updates to the investment portfolio of Harbor Investment Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Harbor Investment Advisory, LLC with notifications on news.